583 related articles for article (PubMed ID: 17432541)
1. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
Rojas-Urdaneta JE; Poleo-Romero AG
Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
[TBL] [Abstract][Full Text] [Related]
3. Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus.
Lubaki LJ; Ghanem G; Vereecken P; Fouty E; Benammar L; Vadoud-Seyedi J; Dell'Anna ML; Briganti S; Picardo M; Heenen M
Arch Dermatol Res; 2010 Mar; 302(2):131-7. PubMed ID: 19547993
[TBL] [Abstract][Full Text] [Related]
4. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
Kumaran MS; Kaur I; Kumar B
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
Bakis-Petsoglou S; Le Guay JL; Wittal R
Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
Dawid M; Veensalu M; Grassberger M; Wolff K
J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
8. Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.
Katayama I; Ashida M; Maeda A; Eishi K; Murota H; Bae SJ
Eur J Dermatol; 2003; 13(4):372-6. PubMed ID: 12948918
[TBL] [Abstract][Full Text] [Related]
9. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
[TBL] [Abstract][Full Text] [Related]
11. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.
Agarwal S; Ramam M; Sharma VK; Khandpur S; Pal H; Pandey RM
Br J Dermatol; 2005 Jul; 153(1):163-6. PubMed ID: 16029343
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
13. Response of vitiligo to narrowband ultraviolet B and oral antioxidants.
Elgoweini M; Nour El Din N
J Clin Pharmacol; 2009 Jul; 49(7):852-5. PubMed ID: 19553407
[TBL] [Abstract][Full Text] [Related]
14. Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin: a double-blind, placebo-controlled study.
Palombo P; Fabrizi G; Ruocco V; Ruocco E; Fluhr J; Roberts R; Morganti P
Skin Pharmacol Physiol; 2007; 20(4):199-210. PubMed ID: 17446716
[TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
[TBL] [Abstract][Full Text] [Related]
16. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
Camacho F; Mazuecos J
J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
[TBL] [Abstract][Full Text] [Related]
17. Vitiligo: new and emerging treatments.
Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
[TBL] [Abstract][Full Text] [Related]
18. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
Zailaie MZ
Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
[TBL] [Abstract][Full Text] [Related]
19. Methanol extract of Desmodium gangeticum roots preserves mitochondrial respiratory enzymes, protecting rat heart against oxidative stress induced by reperfusion injury.
Kurian GA; Yagnesh N; Kishan RS; Paddikkala J
J Pharm Pharmacol; 2008 Apr; 60(4):523-30. PubMed ID: 18380926
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo.
Zailaie MZ
Saudi Med J; 2004 Nov; 25(11):1656-63. PubMed ID: 15573197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]